Evidence map›Paper›PMID 29561195›Full record

ArticleAdipocyte2018

A role for FGF2 in visceral adiposity-associated mammary epithelial transformation.

Vanessa Benham, Debrup Chakraborty, Blair Bullard, Jamie J Bernard

Open access · goldAbstract read
In one paragraph

Article in Adipocyte, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Effects ofFrontiers in veterinary science · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vanessa Benhama Department of Pharmacology and Toxicology , Michigan State University , East Lansing , MI , United States.
Debrup Chakrabortya Department of Pharmacology and Toxicology , Michigan State University , East Lansing , MI , United States.
Blair Bullarda Department of Pharmacology and Toxicology , Michigan State University , East Lansing , MI , United States.
Jamie J Bernarda Department of Pharmacology and Toxicology , Michigan State University , East Lansing , MI , United States.
Michigan State University · US

Funding

MULTIDISCIPLINARY TRAINING IN ENVIRONMENTAL TOXICOLOGYT32ES007255 · NIEHS · MICHIGAN STATE UNIVERSITY · PI JOHN J LAPRES · 1989 to 2026
$9.3M
NIEHS NIH HHS T32 ES007255
6 · The paper itself

Abstract

Obesity is a leading risk factor for post-menopausal breast cancer, and this is concerning as 40% of cancer diagnoses in 2014 were associated with overweight/obesity. Despite this epidemiological link, the underlying mechanism responsible is unknown. We recently published that visceral adipose tissue (VAT) releases FGF2 and stimulates the transformation of skin epithelial cells. Furthermore, obesity is differentially associated with many epithelial cancers, and this mechanistic link could be translational. As FGF2 and FGFR1 are implicated in breast cancer progression, we hypothesize that VAT-derived FGF2 plays a translational role in promoting adiposity-associated mammary epithelial cell transformation. In this brief report, data suggest that FGF2/FGFR1 signaling is a potential mechanistic link in VAT-stimulated transformation of breast epithelial cells.

Indexed as

Epithelial-Mesenchymal TransitionCells, CulturedEpithelial CellsFibroblast Growth Factor 2HumansIntra-Abdominal FatSkinFibroblast Growth Factor 2adipositybreastbreast cancercancerFGF2Obesityvisceral fat

Identifiers

PMID29561195
PMCPMC6152512
OpenAlexW2793676990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.